Drug:
Reaction: MYELOSUPPRESSION
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26914546 |
CN |
61 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 202 | 26904624 |
CN |
58 | 2 |
Temperature intolerance, Myelosuppression, Agranulocytosis, Pyrexia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, EPIRUBICIN HYDROCHLORIDE, |
||||
| 203 | 26905150 |
US |
63 | 2 |
Myelodysplastic syndrome, Myelosuppression, Pancytopenia, Herpes simplex, Toxicity to various agents, Febrile neutropenia, |
||||
PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 204 | 26905227 |
CN |
77 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 205 | 26905233 |
CN |
59 | 2 |
Myelosuppression, Drug eruption, |
||||
PEMETREXED DISODIUM, PEMETREXED DISODIUM, |
||||
| 206 | 26905234 |
CN |
61 | 2 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 207 | 26905243 |
CN |
70 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 208 | 26905270 |
CN |
66 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 209 | 26905299 |
CN |
48 | 1 |
Myelosuppression, Gastrointestinal disorder, |
||||
| 210 | 26905325 |
CN |
59 | 2 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 211 | 26905550 |
CN |
49 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
TRASTUZUMAB, PERTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 212 | 26905570 |
CN |
70 | 1 |
Myelosuppression, |
||||
| 213 | 26905580 |
JP |
8 | |
Myelosuppression, |
||||
POLATUZUMAB VEDOTIN, |
||||
| 214 | 26905864 |
CN |
59 | 2 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 215 | 26905877 |
CN |
63 | 2 |
White blood cell count decreased, Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, |
||||
| 216 | 26905940 |
CN |
68 | 1 |
Myelosuppression, |
||||
OSIMERTINIB, PEMBROLIZUMAB, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 217 | 26906053 |
CN |
40 | 2 |
Myelosuppression, |
||||
TENOFOVIR DISOPROXIL FUMARATE, TENOFOVIR DISOPROXIL FUMARATE TABLETS, |
||||
| 218 | 26906655 |
CN |
45 | 2 |
Myelosuppression, Granulocyte count decreased, |
||||
RIBOCICLIB, |
||||
| 219 | 26906787 |
CN |
65 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, TRASTUZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, CARBOPLATIN, |
||||
| 220 | 26906913 |
CN |
49 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Pyrexia, |
||||
PERTUZUMAB, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 221 | 26906959 |
US |
||
Hypertension, Thrombocytopenia, Cystitis haemorrhagic, Nausea, Vomiting, Neuropathy peripheral, Fatigue, Myelosuppression, Ototoxicity, Rash, Constipation, Oedema, |
||||
BEVACIZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 222 | 26907151 |
CN |
75 | 2 |
Myelosuppression, Granulocyte count decreased, |
||||
SELPERCATINIB, |
||||
| 223 | 26907205 |
CN |
61 | 1 |
Malignant neoplasm progression, Septic shock, Neutropenia, Confusional state, Leukopenia, Small intestinal obstruction, Gastrointestinal bacterial infection, Tremor, Immune-mediated lung disease, Pleural effusion, Cerebellar ataxia, Oesophageal haemorrhage, Hypoalbuminaemia, Myelosuppression, Paraneoplastic neurological syndrome, Gastrooesophageal reflux disease, Pneumonia, |
||||
NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, CISPLATIN, CISPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 224 | 26907293 |
CN |
60 | 2 |
Myelosuppression, Asthenia, Decreased appetite, |
||||
CYTARABINE, |
||||
| 225 | 26907296 |
CN |
60 | 1 |
Myelosuppression, Infection, Fatigue, Headache, Productive cough, Pneumonia viral, |
||||
CYTARABINE, METHOTREXATE SODIUM, |
||||
| 226 | 26907491 |
CN |
71 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 227 | 26907746 |
56 | 2 | |
Myelosuppression, |
||||
| 228 | 26907752 |
CN |
54 | 2 |
Myelosuppression, Platelet count decreased, Bacteraemia, Urinary tract infection, Nausea, Vomiting, |
||||
BEVACIZUMAB, CISPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 229 | 26907889 |
59 | 2 | |
Myelosuppression, |
||||
| 230 | 26907992 |
TH |
66 | 2 |
Myelosuppression, |
||||
OLAPARIB, OLAPARIB, OLAPARIB, |
||||
| 231 | 26908543 |
CN |
8 | 2 |
Myelosuppression, Septic shock, Gastrointestinal infection, Abdominal pain, Hypotension, Diarrhoea, Vomiting, Pyrexia, |
||||
CYTARABINE, CYTARABINE, PEGASPARGASE, METHOTREXATE, METHOTREXATE SODIUM, VINCRISTINE SULFATE, DEXAMETHASONE SODIUM PHOSPHATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 232 | 26909320 |
CN |
61 | 1 |
Myelosuppression, Nausea, |
||||
ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, CISPLATIN, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 233 | 26909335 |
CN |
74 | 2 |
Myelosuppression, |
||||
OXALIPLATIN, |
||||
| 234 | 26909344 |
CN |
68 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 235 | 26909345 |
CN |
62 | 1 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, |
||||
| 236 | 26909382 |
CN |
58 | 2 |
Myelosuppression, Pyrexia, |
||||
GEMCITABINE HYDROCHLORIDE, |
||||
| 237 | 26909439 |
CN |
69 | 1 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 238 | 26903904 |
JP |
62 | 2 |
Myelosuppression, |
||||
AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT), AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT), CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 239 | 26904327 |
JP |
64 | 1 |
Myelosuppression, Prostate cancer, Malignant neoplasm progression, Therapeutic product effect incomplete, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 240 | 26904457 |
CN |
56 | 1 |
Myelosuppression, |
||||
CARFILZOMIB, ETOPOSIDE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, CISPLATIN, |
||||
| 241 | 26904470 |
CN |
64 | 1 |
Myelosuppression, |
||||
DARATUMUMAB, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 242 | 26902717 |
CN |
57 | 2 |
Myelosuppression, Neutrophil count decreased, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 243 | 26903000 |
US |
||
Myelosuppression, Orthostatic hypotension, Dizziness, Product use in unapproved indication, |
||||
CARBOPLATIN, |
||||
| 244 | 26903104 |
US |
1 | |
Myelosuppression, Urticaria, Blood iron decreased, Pyrexia, Fatigue, Product use in unapproved indication, |
||||
CLOFARABINE, |
||||
| 245 | 26903376 |
CN |
47 | 1 |
Myelosuppression, |
||||
VENETOCLAX, |
||||
| 246 | 26903377 |
CN |
86 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 247 | 26903404 |
US |
2 | |
Myelosuppression, Febrile neutropenia, Potentiating drug interaction, Odynophagia, Mucosal inflammation, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHIMAZOLE, |
||||
| 248 | 26903412 |
US |
2 | |
Myelosuppression, Febrile neutropenia, Potentiating drug interaction, Odynophagia, Mucosal inflammation, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHIMAZOLE, |
||||
| 249 | 26903429 |
CN |
84 | 1 |
Myelosuppression, |
||||
TRASTUZUMAB, OXALIPLATIN, |
||||
| 250 | 26897858 |
CN |
35 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, |
||||
| 251 | 26898310 |
CN |
16 | 2 |
Myelosuppression, White blood cell count decreased, |
||||
IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 252 | 26898313 |
CN |
36 | 2 |
Myelosuppression, Off label use, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 253 | 26898319 |
CN |
72 | 1 |
Myelosuppression, Interstitial lung disease, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), TOLVAPTAN, |
||||
| 254 | 26898799 |
CN |
67 | 1 |
Myelosuppression, Performance status decreased, Asthenia, Decreased appetite, |
||||
FRUQUINTINIB, |
||||
| 255 | 26899019 |
CN |
64 | 1 |
Agranulocytosis, Myelosuppression, Pyrexia, Platelet disorder, White blood cell count abnormal, |
||||
OXALIPLATIN, IRINOTECAN HYDROCHLORIDE, |
||||
| 256 | 26899536 |
EU |
||
Acute myeloid leukaemia, Infection, Bacteraemia, Pneumonia, Thrombocytopenia, Neutropenia, Haematotoxicity, Myelosuppression, Anaemia, Hepatic enzyme increased, Febrile neutropenia, Sepsis, Unevaluable event, Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, |
||||
| 257 | 26899651 |
TR |
50 | 2 |
Anaemia, Myelosuppression, Immunoglobulins decreased, Blood disorder, |
||||
OCRELIZUMAB, |
||||
| 258 | 26899794 |
CN |
62 | 1 |
Myelosuppression, Off label use, |
||||
FRUQUINTINIB, IRINOTECAN HYDROCHLORIDE, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 259 | 26899801 |
CN |
62 | 2 |
Myelosuppression, Nausea, Vomiting, White blood cell count decreased, Blood albumin decreased, Neutrophil count decreased, |
||||
ZOLBETUXIMAB, CAPECITABINE, |
||||
| 260 | 26899943 |
CN |
56 | 1 |
Myelosuppression, Diarrhoea, Asthenia, Pyrexia, |
||||
BEVACIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, |
||||
| 261 | 26900622 |
55 | 1 | |
Myelosuppression, Dermatitis, |
||||
PEMETREXED DISODIUM, PEMETREXED DISODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 262 | 26900755 |
JP |
77 | 1 |
Myelosuppression, Non-small cell lung cancer, Lung neoplasm malignant, Diarrhoea, |
||||
DURVALUMAB, TREMELIMUMAB, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 263 | 26901258 |
2 | ||
Myelosuppression, |
||||
| 264 | 26901259 |
2 | ||
Myelosuppression, |
||||
| 265 | 26901395 |
CN |
57 | 1 |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 266 | 26902000 |
CN |
79 | |
Granulocytopenia, White blood cell count decreased, Myelosuppression, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 267 | 26902344 |
52 | 2 | |
Myelosuppression, Back pain, |
||||
ABEMACICLIB, |
||||
| 268 | 26902406 |
CN |
5 | 2 |
Myelosuppression, Pyrexia, White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, |
||||
BEVACIZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DACTINOMYCIN, VINCRISTINE SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 269 | 26902639 |
CN |
63 | 1 |
Myelosuppression, Myelosuppression, Diarrhoea, Vomiting, Pyrexia, Diarrhoea, Diarrhoea, Urticaria, Abdominal discomfort, Dermatitis allergic, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, CYTARABINE, CYTARABINE, CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 270 | 26892006 |
CN |
36 | 1 |
Myelosuppression, Acute myeloid leukaemia, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, CYTARABINE, |
||||
| 271 | 26892251 |
CN |
62 | 2 |
Myelosuppression, |
||||
ADO-TRASTUZUMAB EMTANSINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 272 | 26892673 |
CN |
58 | 2 |
Myelosuppression, Asthenia, Off label use, |
||||
BEVACIZUMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 273 | 26893038 |
CN |
70 | 2 |
Myelosuppression, Asthenia, Dizziness, Chest discomfort, Dyspnoea, Palpitations, Abdominal distension, |
||||
BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 274 | 26893151 |
JP |
7 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 275 | 26893248 |
CN |
52 | 2 |
Myelosuppression, Off label use, |
||||
FRUQUINTINIB, |
||||
| 276 | 26893940 |
CN |
58 | 2 |
Myelosuppression, |
||||
OSIMERTINIB, |
||||
| 277 | 26894189 |
CN |
65 | 2 |
Myelosuppression, Abdominal discomfort, Vomiting, |
||||
OXALIPLATIN, PEMBROLIZUMAB, |
||||
| 278 | 26894298 |
CN |
16 | 2 |
Myelosuppression, Platelet count decreased, Haemoglobin decreased, |
||||
IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 279 | 26894459 |
CN |
59 | 1 |
Myelosuppression, C-reactive protein increased, |
||||
CYTARABINE, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 280 | 26894873 |
58 | 2 | |
Death, Myelosuppression, Nausea, Vomiting, |
||||
GEMCITABINE HYDROCHLORIDE, OXALIPLATIN, |
||||
| 281 | 26894926 |
CN |
52 | 1 |
Myelosuppression, Platelet count decreased, Neutrophil count decreased, White blood cell count decreased, |
||||
CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 282 | 26895514 |
|||
Myelosuppression, Febrile neutropenia, Odynophagia, Mucosal inflammation, Potentiating drug interaction, |
||||
METHIMAZOLE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 283 | 26895899 |
44 | 2 | |
Myelosuppression, |
||||
| 284 | 26896176 |
CN |
65 | 2 |
Myelosuppression, Product use issue, Abdominal discomfort, Vomiting, |
||||
PEMBROLIZUMAB, |
||||
| 285 | 26886578 |
US |
2 | |
Drug interaction, Myelosuppression, Toxicity to various agents, Odynophagia, Mucosal inflammation, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHIMAZOLE, METHIMAZOLE, |
||||
| 286 | 26886613 |
CN |
68 | 2 |
Myelosuppression, |
||||
ABEMACICLIB, FULVESTRANT, |
||||
| 287 | 26886771 |
CN |
73 | 1 |
Myelosuppression, |
||||
TRASTUZUMAB, OXALIPLATIN, |
||||
| 288 | 26886948 |
JP |
1 | |
Myelosuppression, |
||||
OLAPARIB, |
||||
| 289 | 26886977 |
CN |
61 | 1 |
Myelosuppression, |
||||
| 290 | 26887187 |
CN |
51 | 2 |
Myelosuppression, |
||||
EXEMESTANE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 291 | 26887254 |
CN |
31 | 2 |
Myelosuppression, |
||||
RITUXIMAB, ETOPOSIDE, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ACYCLOVIR, THALIDOMIDE, METHOTREXATE, METHOTREXATE SODIUM, CYTARABINE, |
||||
| 292 | 26888393 |
CN |
||
Myelosuppression, Hypersensitivity, Cardiotoxicity, Neurotoxicity, Myalgia, Arthralgia, Nausea, Vomiting, Diarrhoea, Respiratory disorder, Skin reaction, Hepatic function abnormal, Renal impairment, |
||||
TRASTUZUMAB, TRASTUZUMAB, |
||||
| 293 | 26888804 |
CN |
35 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Lymphocyte count decreased, |
||||
CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 294 | 26888822 |
CN |
54 | 2 |
Myelosuppression, Flank pain, Back pain, Asthenia, Hypoaesthesia, |
||||
TRASTUZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 295 | 26888872 |
CN |
38 | 2 |
Myelosuppression, White blood cell count decreased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 296 | 26888873 |
US |
64 | 2 |
Drug ineffective, Pancytopenia, Acute hepatic failure, Myelosuppression, Haemophagocytic lymphohistiocytosis, Rebound effect, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ETOPOSIDE, ETOPOSIDE, |
||||
| 297 | 26888878 |
CN |
27 | 1 |
Myelosuppression, Sepsis, Blood pressure decreased, |
||||
CYTARABINE, |
||||
| 298 | 26888891 |
CN |
7 | 1 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CYTARABINE, MERCAPTOPURINE, |
||||
| 299 | 26888908 |
CN |
51 | 2 |
Myelosuppression, |
||||
| 300 | 26889000 |
CN |
47 | 1 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, STERILE WATER FOR INJECTION, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30